Cheat sheet

DHA Pharmacist Exam Cheat Sheet

Toxicology

Not publishedof exam

AntidotesToxidromesDecontaminationOverdose Triage

Medicinal Chemistry

Not publishedof exam

Structure ActivityIonizationAntimicrobialsStereochemistry

Sterile & Nonsterile Compounding

Not publishedof exam

Aseptic TechniqueSterile PreparationsNonsterile MethodsCompatibility

Pharmaceutics & Biopharmaceutics

Not publishedof exam

Dosage FormsBCS ClassesDissolutionModified Release

Pharmacognosy & Dietary Supplements

Not publishedof exam

Herb InteractionsSupplement SafetyNatural ProductsPatient Disclosure

Pharmacy Calculations & Compounding

Not publishedof exam

ConcentrationsDose CalculationsInfusion RatesRenal Estimates

Clinical Pharmacogenomics

Not publishedof exam

Gene Drug PairsMetabolizer StatusHLA RiskDose Selection

Infection Control

Not publishedof exam

Hand HygieneInjection SafetySharpsClean Preparation

Pharmacokinetics

Not publishedof exam

ADMEHalf-LifeClearanceDistribution

Pharmaceutical Care & Disease Management

Not publishedof exam

Medication ReviewDisease ManagementCounselingMonitoring

Medication Safety

Not publishedof exam

Five RightsReconciliationHigh AlertError Prevention

Over-the-Counter Medication

Not publishedof exam

Self Care TriageRed FlagsReferralProduct Selection

Pharmacy Law & Ethics

Not publishedof exam

UAE Pharmacy LawConfidentialityControlled MedicinesProfessional Ethics

Clinical Pharmacology & Therapeutic Decisions

Not publishedof exam

ReceptorsDose ResponseInteractionsTherapeutic Choices

Quick Facts

Exam
DHA Pharmacist PHO5481
Authority
Dubai Health Authority
Delivery
Prometric CBT
Format
Multiple-choice questions
Questions
150 questions
Duration
3 hours
Pass Score
60%
Assessment Fee
USD 240
Result
Pass/Fail; score withheld
Coverage Areas
14 published topics
Domain Weights
Not published
Attempt Limit
Three across UAE authorities
Retake Wait
No DHA grace period
Licensing Portal
Sheryan

Poisoning Response Picker

  1. Patient unstableABCs first(Activate emergency response)
  2. Exposure suspectedToxicology guidance(Contact local service)
  3. History availableAgent-dose-time(Include formulation)
  4. Initial assessmentVitals, ECG, glucose(Check temperature)
  5. Unknown ingestionSupportive care(Avoid blind antidotes)
  6. Decontamination consideredToxicology protocol(Never induce emesis)
  7. Specific indicationAppropriate antidote(Check contraindications)
  8. Symptoms improveContinue monitoring(Watch delayed toxicity)

Antidote Map

Paracetamol
N-acetylcysteine
Opioids
Naloxone
Organophosphates
Atropine + pralidoxime
TCA cardiotoxicity
Sodium bicarbonate
Methanol/ethylene glycol
Fomepizole
Iron
Deferoxamine
Digoxin
Digoxin immune Fab
Heparin
Protamine sulfate
Warfarin
Vitamin K; PCC for emergencies
Methemoglobinemia
Methylene blue; check G6PD

Toxidromes & First Response

Opioid toxidrome
Miosis, respiratory depression, coma
Anticholinergic
Hot, dry, dilated, delirious
Cholinergic
Secretions, bradycardia, bronchospasm
Sympathomimetic
Agitation, diaphoresis, tachycardia
Serotonin syndrome
Clonus, hyperreflexia, hyperthermia
Neuroleptic malignant syndrome
Rigidity, hyporeflexia, hyperthermia
First priority
ABCs and emergency support
Activated charcoal
Selected early ingestions
Induced emesis
Never routine
Poison guidance
Contact local toxicology service

Structure-Activity Clues

pKa
Ionization depends on environmental pH
Unionized drug
Crosses lipid membranes more readily
Lipophilicity
Often increases membrane penetration
Beta-lactam ring
Binds PBPs; blocks cross-linking
Sulfonamides
PABA pathway antagonists
Fluoroquinolones
Inhibit gyrase/topoisomerase IV
Macrolides
Bind bacterial 50S ribosome
Aminoglycosides
Bind bacterial 30S ribosome
Stereoisomers
Configuration may change activity
Prodrug
Activation creates active moiety

Sterile vs Nonsterile Compounding

Sterile

  • Aseptic environment required
  • Critical sites protected

Nonsterile

  • Clean technique required
  • Uniformity remains essential

Route drives sterility need

Compounding Essentials

Aseptic technique
Prevents microbial contamination
Critical site
Never touch or obstruct
HEPA filter
Removes airborne particles
Unidirectional airflow
Sweeps contaminants away
LAFW
Nonhazardous product protection
BSC
Hazardous sterile product containment
Geometric dilution
Incrementally mixes unequal amounts
Levigation
Smooths powder with liquid
Trituration
Grinds and mixes powders
Aliquot method
Measures tiny quantities indirectly
Eutectic pair
May liquefy when mixed
Final label
Strength, route, storage, BUD

Pharmaceutics Essentials

BCS Class I
High solubility, high permeability
BCS Class II
Low solubility, high permeability
BCS Class III
High solubility, low permeability
BCS Class IV
Low solubility, low permeability
Smaller particles
Usually dissolve faster
Higher surface area
Usually accelerates dissolution
Enteric coating
Delays release until intestine
Modified release
Avoid crushing unless approved
Suspension
Shake before measuring
Emulsion
Two immiscible liquid phases
Surfactant
Lowers interfacial tension
First-pass effect
Lowers systemic bioavailability

Supplement Interaction Flags

St John's wort
Induces CYP3A4 and P-gp
Ginkgo
May increase bleeding
Garlic supplements
May increase bleeding
Ginseng
May lower glucose
Licorice
May raise BP, lower potassium
Kava
Hepatotoxicity and sedation concern
Valerian
May add sedation
Grapefruit
Inhibits intestinal CYP3A4
Natural label
Does not guarantee safety
Supplement history
Ask product, dose, frequency
Interaction action
Check before recommending
Pregnancy
Avoid unverified herbal products

Calculation Safety

Units first, estimate, calculate, verify

Align unitsEstimate answerCalculate onceVerify plausibility

Calculation Picker

  1. Need dose volumeDose / concentration(Align units first)
  2. Need dilution volumeC1V1 = C2V2(Same concentration units)
  3. Weight-based ordermg/kg × kg(Check dose maximum)
  4. BSA-based ordermg/m² × BSA(Verify BSA units)
  5. Pump infusionmL / hours(Convert time first)
  6. Gravity infusionDrops/min formula(Use tubing factor)
  7. Need rapid targetLoading dose(Driven by Vd)
  8. Need ongoing exposureMaintenance dose(Driven by clearance)

Calculation Formulae

Dose volume
Ordered dose / concentration
C1V1 = C2V2
Dilution equation
% w/v
Grams per 100 mL
% v/v
Milliliters per 100 mL
1:x w/v
One gram per x mL
mg/kg dose
Dose factor × weight
BSA dose
mg/m² × BSA
Infusion rate
Volume / hours
Drops/min
Volume × drop factor / minutes
Quantity dispensed
Dose × frequency × days
Loading dose
Target concentration × Vd / F
Maintenance rate
Target concentration × clearance / F
Cockcroft-Gault
(140−age) × kg / (72 × SCr)
Female CG factor
Multiply estimate by 0.85
Dimensional analysis
Cancel units before calculating
Final check
Units, plausibility, rounding

Gene-Drug Pairs

CYP2C19 poor metabolizer
Reduced clopidogrel activation
HLA-B*57:01
Abacavir hypersensitivity risk
HLA-B*15:02
Carbamazepine SJS/TEN risk
TPMT/NUDT15
Thiopurine myelotoxicity risk
DPYD variant
Fluoropyrimidine toxicity risk
UGT1A1 reduced function
Irinotecan toxicity risk
CYP2D6 ultrarapid
Codeine toxicity risk
CYP2D6 poor
Reduced codeine activation
SLCO1B1 variant
Statin myopathy risk
VKORC1/CYP2C9
Warfarin dose sensitivity
Genotype result
Interpret with phenotype
Clinical action
Follow current prescribing guidance

Infection Control Essentials

Before aseptic task
Perform hand hygiene
Visible soil
Use soap and water
Clean hands
Alcohol rub often preferred
Gloves
Never replace hand hygiene
Preparation area
Keep designated and clean
Single-dose vial
One patient only
Needle and syringe
One patient, one use
Every vial entry
Use new needle and syringe
Vial septum
Disinfect before entry
Multidose vial
Dedicate when possible
Used sharps
Discard immediately
Insulin pen
One patient only

ADME

Absorb, distribute, metabolize, eliminate

A = absorptionD = distributionM = metabolismE = elimination

Loading vs Maintenance Dose

Loading

  • Reaches target quickly
  • Driven mainly by Vd

Maintenance

  • Replaces eliminated drug
  • Driven mainly by clearance

Vd loads; clearance maintains

Pharmacokinetic Core

Absorption
Entry into systemic circulation
Bioavailability F
Systemically available fraction
Vd
Amount in body / concentration
Clearance
Elimination rate / concentration
Half-life
0.693 × Vd / clearance
Steady state
Usually four to five half-lives
Loading dose driver
Volume of distribution
Maintenance dose driver
Clearance
First-order elimination
Constant fraction per time
Zero-order elimination
Constant amount per time
Enzyme induction
Often lowers substrate exposure
Enzyme inhibition
Often raises substrate exposure
Renal impairment
Often reduces drug clearance

PK Dose Drivers

Volume loads; clearance maintains

Loading = VdMaintenance = clearanceHalf-life uses both

First-Order vs Zero-Order

First-Order

  • Constant fraction eliminated
  • Half-life usually constant

Zero-Order

  • Constant amount eliminated
  • Pathway capacity saturated

Fraction versus amount

IESA Medication Review

Indication, effectiveness, safety, adherence

I = neededE = workingS = safeA = taken

Pharmaceutical Care Review

Unnecessary therapy
No valid indication
Additional therapy
Untreated condition or prevention
Ineffective therapy
Wrong medicine or formulation
Dose too low
Insufficient exposure or frequency
Adverse reaction
Medicine causes harmful response
Dose too high
Excess exposure or frequency
Nonadherence
Regimen not followed
Interaction screen
Drug, food, disease
Renal function
Adjust medicine and interval
Treatment goal
Define measurable patient outcome
Teach-back
Confirms patient understanding
Follow-up
Reassess outcome and safety

Five Rights

Patient, drug, dose, route, time

Right patientRight drugRight doseRight routeRight time

Allergy vs Side Effect

Allergy

  • Immune-mediated reaction
  • May preclude re-exposure

Side Effect

  • Known pharmacologic effect
  • May be manageable

Document reaction details

Medication Error Response

  1. Error interceptedStop process(Prevent administration)
  2. Exposure possibleAssess patient(Stabilize first)
  3. Harm suspectedEscalate immediately(Follow emergency protocol)
  4. Treatment neededNotify prescriber(Use verified facts)
  5. Patient affectedFollow disclosure policy(Communicate transparently)
  6. Immediate risk controlledReport event(Include near misses)
  7. Record requiredDocument objectively(Avoid blame)
  8. Review completedAdd system control(Prevent recurrence)

Medication Safety Controls

Right patient
Use two identifiers
Right drug
Verify product and label
Right dose
Calculate and range-check
Right route
Verify form and compatibility
Right time
Check schedule and interactions
Allergy check
Verify before dispensing
Reconciliation
Compare complete medication lists
High-alert medicine
Use independent double-check
Look-alike names
Separate and use Tall Man
Leading zero
Write 0.5 mg
Trailing zero
Never write 5.0 mg
Oral liquid
Use oral syringe
Near miss
Report and analyze
Barcode
Does not replace vigilance
Medication error
Protect patient first

Medication Error vs Adverse Reaction

Medication Error

  • Preventable process failure
  • May cause no harm

Adverse Reaction

  • Harmful medicine response
  • May occur correctly used

Classify before reporting

WWHAM Self-Care

Who, what, how long, actions, medicines

Who is itWhat symptomsHow longActions triedMedicines used

OTC Triage Picker

  1. Emergency symptomsEmergency pathway(Do not delay)
  2. Serious red flagUrgent referral(Avoid masking symptoms)
  3. Pregnant or breastfeedingVerify safety(Consider trimester)
  4. Very young childAge-specific pathway(Check local limits)
  5. Major comorbidityInteraction check(Renal, hepatic, cardiac)
  6. Duplicate ingredientsSimplify product(Prevent overdose)
  7. Mild self-limited problemShort self-care trial(Give stop rules)
  8. Persistent or worseningClinical referral(Reassess diagnosis)

OTC Referral Flags

Chest pain
Emergency evaluation
Severe dyspnea
Emergency evaluation
Anaphylaxis signs
Emergency treatment
GI bleeding signs
Urgent referral
Severe dehydration
Urgent referral
Young infant fever
Follow urgent local pathway
Pregnancy/lactation
Verify product safety
Renal/hepatic disease
Check before self-care
Persistent symptoms
Refer for assessment
Worsening symptoms
Stop self-care; refer
Oral decongestant
Caution uncontrolled hypertension
NSAID
Check GI, renal, bleeding risks
Combination product
Check duplicate ingredients
Self-care advice
Give duration and stop rules

Pharmacist vs Clinical Pharmacy

Pharmacist

  • Code PHO5481
  • Pass score 60%
  • This sheet's target

Clinical Pharmacy

  • Code PHO5482
  • Pass score 70%
  • Separate DHA assessment

Match title and code

DHA Licensing Path

  1. Starting applicationSelf-Assessment Tool(Check PQR eligibility)
  2. Credentials acceptedPrimary source verification(DataFlow process)
  3. CBT requiredPrometric assessment(Use eligibility ID)
  4. Requirements completedGet Registered(DHA reviews application)
  5. Registration issuedFind licensed facility(Cannot practice yet)
  6. Facility hiresActivate license(Facility completes activation)
  7. License activePractice within scope(Follow DHA requirements)
  8. Expiry approachesRenew timely(Maintain requirements)

UAE Law & Ethics

Dubai regulator
Dubai Health Authority
Practice permission
Active professional license
Registration
Eligibility before license activation
License activation
Completed by hiring facility
Professional scope
Stay within licensed activity
Confidentiality
Protect patient information
Professional duty
Accuracy, honesty, patient welfare
Controlled possession
Requires legal authorization
Controlled dispensing
Only legally permitted cases
Controlled prescription
Record on national platform
Federal law text
Original Arabic controls
Local procedure
Follow authority and facility rules

Registration vs Active License

Registration

  • Confirms title eligibility
  • Precedes facility activation

Active License

  • Permits professional practice
  • Activated by hiring facility

Registration alone forbids practice

Prescription vs Controlled Medicine

Prescription Medicine

  • Requires valid prescription
  • Standard records apply

Controlled Medicine

  • Additional legal restrictions
  • National tracking applies

Controlled rules are stricter

Potency vs Efficacy

Potency

  • Dose needed
  • Reflected by EC50

Efficacy

  • Maximum effect
  • Reflected by Emax

More potent is not stronger

Interaction Checker

  1. Two agents flaggedIdentify perpetrator(And affected substrate)
  2. Concentration changesPK mechanism(ADME interaction)
  3. Effects combinePD mechanism(Bleeding, sedation, QT)
  4. Timing may helpSeparate administration(Only when evidence supports)
  5. Patient risk highAvoid combination(Choose alternative)
  6. Combination necessaryMonitor or adjust(Define measurable endpoint)
  7. Plan selectedCounsel patient(Give warning signs)
  8. Action completedDocument rationale(Arrange follow-up)

Pharmacodynamics Core

Agonist
Activates receptor response
Antagonist
Blocks receptor activation
Partial agonist
Lower maximal receptor response
Potency
Dose needed for effect
Efficacy
Maximum achievable effect
Affinity
Binding strength at receptor
EC50
Concentration producing half-maximal effect
Competitive antagonist
Shifts dose-response right
Noncompetitive antagonist
Lowers maximal effect
Therapeutic index
Toxic dose / effective dose
Additive effect
Combined effects sum
Synergistic effect
Combined effect exceeds sum
Tolerance
Response decreases over time
Tachyphylaxis
Rapidly developing tolerance

Bactericidal vs Bacteriostatic

Bactericidal

  • Kills susceptible bacteria
  • Clinical effect remains context-dependent

Bacteriostatic

  • Inhibits bacterial growth
  • Host defenses aid clearance

Label alone never chooses therapy

Clinical Therapy Alerts

ACE inhibitor
Cough, hyperkalemia, angioedema
ACEI pregnancy
Contraindicated
Beta blocker
Bradycardia; masks hypoglycemia
Loop diuretic
Hypokalemia and volume depletion
Spironolactone
Hyperkalemia risk
NSAID
GI, renal, fluid risks
Statin
Myopathy and interaction check
Warfarin
INR and interaction monitoring
DOAC
Renal function affects dosing
Insulin
Hypoglycemia risk
Sulfonylurea
Hypoglycemia risk
Metformin
Renal function limits use
Aminoglycoside
Nephrotoxicity and ototoxicity
Lithium
Monitor level, renal, thyroid
Chronic corticosteroid
Do not stop abruptly
Antimicrobial choice
Site, culture, allergy, renal

Common Traps

Invented Blueprint Weights

DHA lists 14 areas DHA publishes no percentages

Wrong Pharmacist Code

PHO5481 is Pharmacist PHO5482 is Clinical Pharmacy

Score Report Assumption

Result is Pass/Fail Numeric score is withheld

Registration Confusion

Registration confirms eligibility Active license permits practice

Attempt Rule Confusion

Maximum three across authorities No DHA retake grace period

Strength Conversion Error

1% w/v = 10 mg/mL Convert units before calculating

Unsafe Decimal

Use leading zero Never use trailing zero

Modified-Release Damage

Do not crush routinely Verify product instructions

Glove Substitution

Gloves reduce exposure Hand hygiene remains required

Natural Means Safe

Supplements cause interactions Always collect supplement history

Allergy Mislabeling

Allergy is immune-mediated Side effect may be predictable

Antidote-Only Thinking

ABCs come first Supportive care remains essential

Last Minute

  1. 1.PHO5481 = DHA Pharmacist
  2. 2.PHO5482 = Clinical Pharmacy
  3. 3.150 questions in 3 hours
  4. 4.PHO5481 pass score is 60%
  5. 5.Assessment fee is USD 240
  6. 6.Official coverage has 14 areas
  7. 7.Domain weights are not published
  8. 8.Results report Pass/Fail only
  9. 9.Three attempts across UAE authorities
  10. 10.No DHA retake grace period
  11. 11.Registration is not active licensure
  12. 12.Facility activates professional license
  13. 13.C1V1 equals C2V2 for dilutions
  14. 14.Loading dose follows Vd
  15. 15.Maintenance dose follows clearance
  16. 16.Steady state needs several half-lives
  17. 17.Always align calculation units
  18. 18.Use leading, never trailing zeros
  19. 19.Gloves never replace hand hygiene
  20. 20.One syringe serves one patient
  21. 21.Check renal function before dosing
  22. 22.Natural products still interact
  23. 23.OTC red flags require referral
  24. 24.Poisoning starts with ABCs
  25. 25.Controlled medicines need stricter records
  26. 26.Follow current local clinical protocols
Same family resources

Explore More Gulf Pharmacist Licensing Exams

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.